Technology in Cancer Research & Treatment (Jan 2022)

MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN

  • Chinachote Teerapakpinyo PhD,
  • Wilasinee Areeruk MD,
  • Patou Tantbirojn MD,
  • Vorapong Phupong MD,
  • Shanop Shuangshoti MD,
  • Ruangsak Lertkhachonsuk MD

DOI
https://doi.org/10.1177/15330338211067309
Journal volume & issue
Vol. 21

Abstract

Read online

Objectives: The primary aim of the study was to identify miRNAs that were differentially expressed between complete hydatidiform moles (CHMs) that turned out to be gestational trophoblastic neoplasia (GTN) [GTN moles] and CHMs that regressed spontaneously after evacuation [remission moles]. The secondary aim was to study the profiles of miRNA expressions in CHMs. Methods: A case-control study was conducted on GTN moles and remission moles. We quantitatively assessed the expression of 800 human miRNAs from molar tissues using Nanostring nCounter. Results: From a pilot study, 21 miRNAs were significantly downregulated in GTN moles compared to the remission moles. Five of them (miR-566, miR-608, miR-1226-3p, miR-548ar-3p and miR-514a-3p) were downregulated for >4 folds. MiR-608 was selected as a candidate for further analysis on 18 CHMs (9 remission moles and 9 GTN moles) due to its striking association with malignant formation. MiR-608 expression was slightly lower in GTN moles compared to the remission moles, that is, 2.22 folds change [p = 0.063]. Conclusion: We identified 21 miRNAs that were differentially expressed between GTN moles and remission moles suggesting that miRNA profiles can distinguish between the two groups. Although not reaching statistically significant, miR-608 expression was slightly lower in GTN moles compared to remission moles.